Image

Study of ICG Fluorescence Imaging in Open Fracture and Infection Patients

Study of ICG Fluorescence Imaging in Open Fracture and Infection Patients

Recruiting
18 years and older
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

The purpose of this study is to determine whether an indocyanine green (ICG) fluorescence imaging system (cBPI) can be used to provide surgeons with information about bone health or bone blood flow. This will help surgeons better understand the healing potential of bone and relative risk of complication. This is important to help surgeons select the most appropriate treatment for severe traumatic injuries and infections.

Eligibility

Inclusion Criteria:

  • Patients 18 years of age or older.
  • Open extremity fracture, planning for management with external fixation, internal fixation or joint fusion.
  • Fracture Related Infection, planning for management with debridement and possible removal of hardware.
  • Will have all planned fracture care surgeries performed by a participating surgeon or delegate.
  • Provision of informed consent.

Exclusion Criteria:

  • Inability of patient to provide informed consent
  • Fracture of the hand.
  • Iodine allergy.
  • Burns at the fracture site.

Study details
    Fractures
    Bone
    Trauma Injury

NCT06793644

Dartmouth-Hitchcock Medical Center

3 July 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.